Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICA: Prednisolone vs Itraconazole vs Combination in Acute ABPA
NCT06174922Phase 3Recruiting
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Dec 2023
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of prednisolone, itraconazole in allergic bronchopulmonary aspergillosis (ABPA), sponsored by Post Graduate Institute of Medical Education and Research. Started Dec 2023; status: recruiting.
02
Drugs
prednisoloneitraconazole
03
Conditions
allergic bronchopulmonary aspergillosis (ABPA)
Beyond the preview
Go deeper on NCT06174922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06174922.